Oncology & Cancer
Dementia tied to hormone-blocking prostate cancer treatment
Alzheimer's disease may be a risk for older prostate cancer patients given hormone-blocking treatment, a large, U.S. government-funded analysis found.
Jul 5, 2019
1
74
Page 10 - News tagged with advanced prostate cancer
Oncology & Cancer
International clinical trial of new drug for men with advanced prostate cancer yields strong result
Today the New England Journal of Medicine published the first results of a phase III international clinical study called TITAN (National Clinical Trials Number 02489318), which evaluated the effectiveness and safety of a ...
Jun 3, 2019
0
10
Oncology & Cancer
New insights into treatment targets for men with advanced prostate cancers
A study published recently in the Journal of Clinical Oncology Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, outlines findings from the largest-ever prospective genomic analysis of advanced ...
May 13, 2019
0
3
Oncology & Cancer
Prostate cancer patients with gene mutation at three times the risk of dying
Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival—and which could be used to pick out patients for more intensive treatment.
May 6, 2019
0
49
Oncology & Cancer
A new method to select the right treatment for advanced prostate cancer
Researchers at Karolinska Institutet in Sweden have identified blood-based biomarkers that may determine which patients will benefit from continued hormonal therapy for advanced prostate cancer. The results are published ...
May 3, 2019
0
69
Medications
Prostate cancer hormone therapy rejected on NHS in England
A prostate cancer drug won't be offered on the NHS any earlier in the treatment plans of patients living with the disease in England, after it failed to pass a cost-effectiveness review.
Apr 8, 2019
0
2
Oncology & Cancer
New nanomedicines for a more efficient and less aggressive treatment of prostate cancer
In Europe, prostate cancer is the most common type of cancer among men with an incidence greater than 100 cases per 100,000 individuals. Furthermore, it is currently the second most common cause of cancer-related deaths among ...
Feb 18, 2019
0
2
Oncology & Cancer
Scientists identify gene contributing to prostate cancer drug resistance
Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.
Jan 15, 2019
0
8
Oncology & Cancer
Time to biochemical failure could be used as surrogate endpoint in treatment: LA prostate cancer
An analysis of the NRG Oncology clinical trial NRG-RTOG 9202 showed that the interval of time to biochemical failure (IBF), or the time it takes for previously treated cancer to return as indicated by prostate specific antigen ...
Dec 20, 2018
0
0
Oncology & Cancer
Surgery unnecessary for many prostate cancer patients
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...
Dec 13, 2018
0
13
